Carditis, or inflammation of the heart, is most conveniently broken down into three categories:

    Pericarditis -      Inflammation of the pericardium
    Myocarditis -     Inflammation of the heart muscle
    Endocarditis -    Inflammation of the endocardium

    Pericarditis, inflammation of the fibroserous sac enclosing the heart, manifests itself as one of three types as a result of the bodies reaction to the infecting agent:

    Acute serofibrinous pericarditis - the result of virus infection
    Acute purulent pericarditis - the result of bacterial infection (except for infection by
        Mycobacterium tuberculosis)
    Chronic pericarditis - the result of infection by M. tuberculosis or fungi
 

ETIOLOGY:

    Virtually any infectious agent that reaches the pericardium is capable of causing pericarditis. The most common viruses causing the disease are members of the Picornaviridae (enteroviruses) while the most common bacteria infecting the pericardium are the pyogenic cocci (Staphylococcus, Streptococcus, Neisseria). Chronic pericarditis is most commonly caused by M. tuberculosis or Histoplasma capsulatum.
 

OVERVIEW OF DISEASE:

    In most cases the infecting microorganism reaches the pericardium via the circulatory system. Rarely the organism will enter the pericardium by direct extension from the lung or direct inoculation during surgery, invasive medical procedures or trauma. The organism colonizes the pericardium and stimulates an inflammatory reaction which can result in destruction of heart tissue. If the infecting organism is a virus there is also viral cell lysis. The inflammatory reaction results in the accumulation of serous or purulent exudate which may in turn cause cardiac tamponade (the exertion of pressure or compression on the heart) and circulatory failure.
 
 

PATHOLOGY:

    Microorganisms reach the pericardium by the blood, lymph, direct extension from pulmonary or myocardial foci of infection, or direct inoculation during surgery, other invasive procedures, or penetrating trauma. Viral infections are usually blood-borne and often infect the myocardium as well as the pericardium. Pneumococci or other primary pulmonary pathogens usually infect the pericardium by extension from an adjacent pneumonitis; the common causes of bacteremias - staphylococci, meningococci and H. influenzae - are more likely to reach the pericardium through the blood-stream. A pre-existing, noninfectious pericarditis, as is seen with uremia or following cardiac surgery, may increase susceptibility to hematogenous bacterial pericarditis.

    Acute serofibrinous pericarditis. The viruses typically causing this disease produce a relatively mild inflammatory reaction that is associated with focal damage to the adjacent myocardium. The response varies from a small amount of serous fluid with mononuclear cells and fibrinogen to a large, neutrophil-rich, bloody effusion. The tissue damage is the result of:

        1.     Direct cellular damage by the infecting virus
        2.     Destruction of viral-infected cells by sensitized T-lymphocytes
        3.     Antibody-dependent, cell-mediated cytotoxicity (null cell-dependent).

    Mild fibrosis and occasional adhesions between visceral and parietal surfaces may mark the healing of viral pericarditis. However, such a fibrotic reaction rarely gives rise to a constrictive pericarditis. The disease is self limiting and rarely fatal.

    Acute purulent pericarditis. The bacteria typically causing this disease produce a relatively strong rapidly progressing purulent reaction. The purulent material contains large numbers of polymorphonuclear leukocytes in a large volume of effusion. The tissue damage is the result of:

        1.     Toxin and enzyme production by the bacteria
        2.     Myocardial damage
        3.     Rapidly progressing cardiac tamponade

    Healing is associated with extensive fibrosis that may progress to a chronic, constrictive pericarditis. The mortality rate exceeds 50%.

    Chronic pericarditis. This is most commonly caused by M. tuberculosis. About 5% of patients with pulmonary tuberculosis will have pericardial involvement. The early granulomatous stages are associated with large pericardial effusions (> 300 ml) that are typically serosanguinous and contain a predominance of mononuclear cells. As the disease evolves, the inflammatory process becomes chronic; fusion of the parietal and visceral pericardium may result, yielding constrictive pericarditis and circulatory failure.
 

CLINICAL SYMPTOMS AND SIGNS:

    Acute serofibrinous pericarditis gives rise to:

        a.     Chest pain - rapid in onset, persistent for several hours to days. It is worse during
                inspiration and recumbency but improves with leaning forward. The pain is usually in the
                upper abdominal region overlying the stomach and may be sharp, dull, constricting and/or
                crushing making clinical differentiation from myocardial infarction difficult. Radiation of
             pain to the left trapezius ridge is particularly characteristic.

        b.     Fever - not prominent

        c.     Malaise

        d.     Pericardial friction rub - this is usually a triphasic sound that resembles scratching or the
                crunch of footsteps on cold snow.

    Acute purulent pericarditis gives rise to:

        a.     Little, if any, chest pain

        b.     Prominent fever and chills from the severe underlying infection

        c.     Cardiac tamponade which leads to:

                (1) Dyspnea
                (2) Agitation
                (3) Orthopnea
                (4) Cough

        d.     Pericardial friction rub - occurs in less than 50% of patients.

    Chronic pericarditis is generally due to M. tuberculosis and the symptoms are those of tuberculosis. These include:

        a.     Fever

        b.     Night sweats

        c.     Weight loss

        d.     Fatigue

        e.     Progressive circulatory failure due to:

                (1) Slowly progressing dyspnea

                (2) Ascites

                (3) Edema

    In general all types of pericarditis may result in:

        a.     Abnormal heart sounds other than those due to pericardial friction
         b.     Pericardial effusion that causes:

                (1) Decreased or muffled heart sounds
                (2) An area of dullness to percussion at the tip of the left scapula (Ewart's sign)
                (3) Pulsus paradoxes
                (4) Cervical venous pressure increase with inspiration (Kussmaul's sign)
                (5) Abnormal EKG
 

TREATMENT:

    The treatment includes bed rest, control of pain with non-steroidal anti-inflammatory agents and anti-microbial therapy based on the species of the infecting agent and its sensitivity pattern.
 
 

ETIOLOGICAL AGENTS:

    Many species of viruses, bacteria, chlamydia, rickettsia, fungi and protozoans can cause myocarditis. However, viruses are the most important infectious agents. Of these, the enteroviruses are the single most important group.
 

OVERVIEW OF DISEASE:

    The disease is an infection of the myocardium or muscle of the heart. The virus is ingested in fecally-contaminated water and/or food and eventually, either directly or indirectly, reaches the heart. There may be a prior skin infection before heart effects are seen. The virus invades the heart muscle cells and causes necrosis of the cells and clinical effects.
 

PATHOLOGY:

    Necrosis of myofibers is seen initially and this may be either patchy or diffuse. An acute inflammatory reaction with polymorphonuclear leukocytes may be seen during the first few days of infection, and this is promptly followed by a mononuclear leukocyte cellular infiltrate by the end of the first week. Late changes include fibrosis and loss of myofibers.

    Myocardial cell damage appears to occur in several ways:

        a.     Direct viral damage (e.g., with the Coxsackie B virus).
        b.     Inhibition of humoral and macrophage-mediated immunity early in the infection.
        c.     T-cell mediated cell lysis late in the disease.
 

DIAGNOSIS:

    In infants and young children the disease progresses rapidly, beginning with fever, tachycardia and listlessness and progressing with signs and symptoms of CNS, gastrointestinal, liver and myocardial involvement. Cardiac failure may be evident within a few days of onset of the illness.

    In older children and adults the illness usually progresses more slowly with generalized manifestations of viral infections localized to:

        a.     Respiratory tract

                (1)     Moderate fever
                (2)     Cough
                (3)     Coryza

        b.     Abdomen

                (1)     Pain
                (2)     Nausea
                (3)     Vomiting

    Myocardial involvement becomes manifest one or two weeks after the initial illness with:

        a.     Fever
        b.     Malaise
        c.     Fatigue
        d.     Dyspnea (labored or difficult breathing)
        e.     Palpitations (tachycardia)
        f.     Altered heart sounds (muffled, transient pericardial rubs)
        g.     Chest pain
        h.     Electrocardiographic changes
        i.     Cardiomegaly
        j.     Pulmonary congestion
        k.     Abnormal laboratory findings:

                (1)     Increased sedimentation rate
                (2)     Increased leukocyte count
                (3)     Increased myocardial isoenzymes

                        (a)     Serum Glutamic Oxaloacetic Transaminase (SGOT)
                        (b)     Creatinine Phosphokinase (CPK)
                        (c)     Lactic Dehydrogenase (LDH)
 

TREATMENT:

    Viral myocarditis is typically a mild disease and responds well to bed rest. Bacterial, fungal and protozoan myocarditis can be treated with the appropriate antibiotics. Glucosteroids and other immunosuppressive drugs are CONTRAINDICATED.
 
 

    Endocarditis, inflammation of the membrane lining the chambers of the heart and covering the cusps of the various valves, is caused directly by microbial colonization of the endocardium or indirectly by induction of autoimmunity, as in acute rheumatic fever. Direct colonization is termed infective endocarditis and is caused by microorganisms physically present in endocardial lesions know as vegetations. The disease may be either acute or chronic.
 

ETIOLOGY:

    Almost all bacteria and many fungi, when they get into the blood stream, can cause infective endocarditis. However, 80% of the cases are caused by streptococci or staphylococci.
 

OVERVIEW:

    Relatively avirulent microorganisms derived from the normal flora of the body cause most cases of infective carditis. They gain access to the blood intermittently, as a result of minor trauma to the mucosa of the oropharynx, gastrointestinal tract or genitourinary tract. Such transient bacteremias usually occur without ill effects but they will lead to endocarditis in patients with an underlying cardiovascular lesion or with a suppressed immune system. Intravenous drug abusers commonly have infective endocarditis due to Staphylococcus aureus from contaminated needles. Blood-borne organisms are deposited on the downstream side of the valves where they colonize and cause disease.
 

PATHOLOGY:

    As bacteria colonize the endocardium, they form vegetations which vary in size from tiny bodies to masses large enough to occlude valve orifices. Often, they are soft and friable and only loosely attached to the endocardium. Thus, they break off easily to form arterial emboli. Fungal vegetations tend to be bulky, giving rise to large emboli. Apart from the propensity to generate emboli, there is no correlation between size of vegetation and severity of endocarditis.

    The bulk of the vegetation is an amorphous mass of fibrin and platelets containing colonies of microorganisms. There may be inflammatory cells attached to the vegetation. There are four consequences to the formation of this vegetation:

    a.     Organisms within the vegetation are protected from antibodies, complement, and leukocytes

     b.    Organisms within the vegetation are metabolically inactive, replicating at an unusually slow
            rate, rendering them relatively resistant to the action of many antimicrobics

    c.     Healing is slow because macrophages and fibroblasts must spread through the vegetation
            and endothelial cells must grow over the surface.

    d.     Emboli are generated when vegetations break off; these cause infarcts.

    Abscesses may develop by direct invasion of the valve rings of the heart near the vegetations. These are common with pyogenic cocci but rare with other organisms.
 

CLINICAL SYMPTOMS:

    The interval between the colonization of the endocardium and the onset of symptoms is two weeks. Death can occur about 6 weeks after colonization if the disease goes untreated. The initial symptoms are those of any infection:

    a.     Low grade fever
    b.     Anorexia
    c.     Fatigue
    d.     Weight loss
    e.     Anemia
    f.     Splenomegaly

    Serologic findings include:

    a.     Hypergammaglobulinemia
    b.     High levels of rheumatoid factor
    c.     High levels of antinuclear antibody
    d.     High levels of circulating immune complexes

    The circulating immune complexes give rise to skin manifestations which include:

    a.     Osler's nodes
    b.     Splinter hemorrhages
    c.     Petechia
    d.     Janeway's lesions
    e.     Roth spots

    Urinary findings may include:

    a.     Proteinuria
    b.     Microscopic hematuria
    c.     Red blood cell casts

    Heart murmur is present at some times during the disease but is generally not constant. If the tricuspid valve is damaged to the extent that there is tricuspid regurgitation, Carvallo's sign will be present; this is augmentation of the pan-cystolic murmur by inspiration.
 

DIAGNOSIS:

    Because the clinical features of the disease can be quite variable and often nonspecific, diagnosis is mainly based on laboratory tests. Blood culture and serologic testing are the most important. Always use venous blood to isolate the organism. A positive blood culture with some or all of the symptoms listed is needed to obtain the diagnosis.
 

TREATMENT:

    Antibiotic therapy must persist for at least 14 days, even if symptoms disappear prior to that time. A combination of antibiotics, rather than a single antibiotic, is always used. If no organism has been isolated after repeated attempts the recommended therapy is:

    Ampicillin, given IV every 4 hours + Gentamycin, given every 8 hours.

    If an organism has been isolated, then the antibiotic regimen is based on the species of the etiologic agent, the age of the patient and the extent of the disease. The regimens are complex and are listed in various reference books.

    If antibiotic therapy is not successful surgical removal of infected endocardium may be necessary. This is especially true with fungal infections and when the patient has an intracardiovascular prosthesis. Nonspecific therapy includes:

    Bed rest
    Low salt diet
    Alleviation of congestive heart failure
    Control of fever
    Transfusion to maintain a hematocrit close to 30%

Anticoagulation with heparin is CONTRAINDICATED.
 
 

ETIOLOGY:

    Chylamydia pneumoniae, a Gram^-, pleomorphic, obligate intracellular parasite.
 

OVERVIEW:

    Myocardial infarction can occur in the absence of the common risk factors such as hypercholesterolemia, diabetes mellitus or cigarette smoking. The sequence of events that leads to acute myocardial infarction includes atherosclerotic plaque formation, plaque rupture, coronary artery thrombosis and coronary occlusion. Anything that leads to plaque rupture can result in myocardial infarction. C. pneumoniae infection is one of those risk factors that can induce plaque rupture. The plaque debris lodges in a blood vessel upon rupture and blocks blood flow.
 

PATHOLOGY:

    The key pathologic features in atherosclerosis are focal intima thickenings and lipid accumulation, producing the characteristic atheromatous plaques. This is a white to yellowish/white body impinging on the lumen of the artery. On section, the superficial portion of these lesions at the luminal surface tends to be firm and white (the fibrous cap) and the deep portions yellow or whitish yellow and soft. The centers of larger plaques may contain a yellow, grumous debris called an atheroma.

    C. pneumoniae is present in the fibrous cap if myocardial infarction is due to an infectious process.
 

SYMPTOMOLOGY:

    The symptomology of myocardial infarction is the same in the non-infectious and infectious disease. The most common presenting complaint is pain which is described as

    Severe (often the worst pain the patient has ever experienced)
    Deep and visceral
    Heavy
    Squeezing
    Crushing

    Typically the pain involves the central portion of the chest and/or epigastrium and in about 30% of cases it radiates to the arms. Fifteen to twenty percent of patients suffer no pain.
 

DIAGNOSIS:

    The combination of substernal chest pain, persistent for more than 30 minutes and diaphoresis strongly suggests acute myocardial infarction. Laboratory findings include:

    1.     Non-specific indices of tissue necrosis and inflammation

            a.     Polymorphonuclear leukocytosis

            b.     Erythrocyte sedimentation rate that rises more slowly than the WBC count

    2.     The electrocardiogram

    3.     Serum enzyme changes

            a.     Creatine phosphokinase (CK)

            b.     Lactic dehydrogeinase (LDH)

    4.     Cardiac imaging

    5.     Presence of chlamidia in the plaque

    6.     Presence of antibiodies to C. pneumoniae
 

TREATMENT:

    Treatment for the infection is administration of one of these compounds (listed in order from most effective to least efficatious):

    Macrolide antibiotics (erythromycin, azithromycin, clarithromycin)
    Tetracyclines
    Fluoroquinolones (ciprofloxacin, norfloxacin and ofloxacin)